Fagron NV
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
09 nov 2009 - 07:41
Statutaire naam
Fagron NV
Titel
Omega Pharma sells 24.04% interest in Arseus for between 8.00 euro and a maximum of 10.75 euro per share
Bericht
WATERLAND BECOMES REFERENCE SHAREHOLDER IN ARSEUS
Waregem (Belgium), 9 November 2009 (07:30 CET) - Omega Pharma NV, Arseus NV and Waterland Private Equity Investments ('Waterland') jointly announce today that Waterland has signed agreements to purchase a minority 25.10% interest in Arseus. Via its fourth fund, Waterland will purchase 7,500,000 shares (24.04%) from Omega Pharma and 330,000 shares (1.06%) from Couckinvest NV at 8.00 euro per Arseus share, plus an earn-out of up to 2.75 euro per share, payable when Waterland exits, depending on the future shareholder value created by Arseus. Completion of the transaction is scheduled for 25 November 2009.
Datum laatste update: 19 december 2025